Back to results
US 2015/0087813 A1Published application
Ligand
AssigneeDomantis Limited
InventorsKevin MOULDER, Ian Tomlinson
Life of this patent
Estimating the term…
Abstract
The invention provides a dual-specific ligand comprising a first immunoglobulin variable domain having a first binding specificity and a complementary or non-complementary immunoglobulin variable domain having a second binding specificity.
Claims1
A ligand comprising a VH3 immunoglobulin single variable domain, wherein said domain specifically binds serum albumin with an equilibrium dissociation constant (Kd) of less than or equal to 300 nM.
Dependencies are inferred from the claim text.